Tumour Detection

3 trials VVarious

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

1 Sponsors

10 Countries

Phase III

Phase III: 3

Sponsors using this IMP

Janssen - Cilag International 3

All trials

3 total

A Study of an Intermittent ADT Approach with Apalutamide Monotherapy in Participants with mCSPC Ended

2022-502686-24-00 Phase III 3 countries Janssen - Cilag International
A study of androgen deprivation therapy (ADT) plus apalutamide in patients with prostate cancer Ended

2023-506153-38-00 Phase III 7 countries Janssen - Cilag International
An Efficacy and Safety Study of JNJ56021927 (ARN509) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS Ended

2023-505246-26-00 Phase III 9 countries Janssen - Cilag International

Showing 1–3 of 3 trials

← All drugs A–Z